I apologize that I took what you were saying about the MHRA as being related to the FDA.I don’t know, or even care much, what the FDA are doing. It doesn’t impact me. I was talking about the MHRA which is the U.K. agency that does much the same thing I guess at the FDA.
What you said was:
1. The FDA reviews a company's raw data which takes more time than what the UK is doing, which is trusting the company.
Incorrect, the MHRA has been doing that since the start with the early raw data, and yes they have been getting the data. As have other EU countries that were contributors to the vaccine development.
2. People complain that they're not going to trust a rushed vaccine and here you are advocating for a rushed vaccine.
Implying that the U.K. is rushing approval, when it just means that the U.K., along with other EU countries, have perhaps had a head start when it comes to analysing the data, since they provided financial backing.
However, it is disconcerting that you would say you don't care what the FDA is doing because I was responding to someone questioning the difference between the US and UK approaches. And if you're going to wade into a compare and contrast between two things... you should know something about both things.
I said the FDA looks at raw data.
You said the MHRA does the same thing and has been doing it all along.
I can't find anything to support what you say about the MHRA. The New York Times quotes an expert who makes the point that the MHRA trusts the analysis of the raw data given to them in reports by the manufacturer. That is different from looking and analyzing the raw data themselves from scratch. It seems the MHRA is looking at Pfizer's analysis of the raw data and trusting their summaries. The FDA painstakingly looks at every data point and makes their own reports.
American and British regulators also conduct their vaccine reviews differently, Dr. Ward said. American regulators ask vaccine makers for raw data, which the F.D.A. reanalyzes to validate company results. Regulators in Britain and elsewhere in Europe rely more heavily on the companies’ own reports, Dr. Ward said, though they reserve the right to verify their accuracy.
Britain Set to Leap Ahead in Approving Vaccines (Published 2020)
Regulators may approve the troubled AstraZeneca vaccine and the American-made Pfizer shot weeks before the U.S. does so.
www.nytimes.com